新型成人及青少年结核疫苗与印度尼西亚:政策规划与证据,2024年11月
2024年11月,印度尼西亚卫生部与世界卫生组织在印度尼西亚召开政策与规划会议,讨论面向成人和青少年的新型结核疫苗。会议提出确保新疫苗在监管批准后尽快可及、可接受的关键建议,并建议采用分层地理策略,优先在疾病和社会经济负担最高的省份实施。
要点
- 会议建议采用分层地理策略引入新结核疫苗,优先在疾病和社会经济负担最高的省份启动。
- 需改进不同年龄队列和人群的疾病、感染流行率及可接受性数据,以支持国家和地方层面的健康与经济影响建模。
- 亟需制定包含关键活动路线图、责任实体和利益相关方参与计划的国家新结核疫苗引入战略规划。
核心结论
- 会议提出多项关键建议,以确保面向成人和青少年的新型结核疫苗在监管批准后尽快在印度尼西亚可及、可及和可接受。
研究设计与样本
- 本报告总结了印度尼西亚卫生部与世界卫生组织于2024年11月在印度尼西亚召开的政策与规划会议。
- 参会者包括印度尼西亚政策制定者、研究人员、卫生倡导者和社区代表,以及全球免疫和结核规划观察员和捐助方。
主要发现
- 印度尼西亚全球结核负担第二高,并正在参与一种领先候选疫苗的III期效力研究,该疫苗可能于2028年获批使用。
- 疫苗实施策略预计采用分层地理方法,从疾病和社会经济负担最高的省份开始。
临床怎么用
- 会议建议采用分层地理策略引入新结核疫苗,优先在疾病和社会经济负担最高的省份启动。
- 会议建议改进不同年龄队列和人群的疾病、感染流行率及可接受性数据,以支持国家和地方层面的健康与经济影响建模。
- 会议建议开展关于成人和青少年新结核疫苗知识、态度和实践的早期研究,以促进社区领袖和倡导者参与并确保有效、文化上可接受的沟通。
- 会议建议制定国家新结核疫苗引入战略规划,包括关键活动路线图、责任实体和利益相关方参与计划。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This report summarizes the proceedings of a policy and planning meeting convened in Indonesia, by the Ministry of Health and the World Health Organization, on potential new tuberculosis (TB) vaccines intended for adults and adolescents. Given that Indonesia bears the second highest TB burden globally, and that it is participating in the phase III efficacy study for one of the leading vaccine candidates that could be approved for use by 2028, the meeting aimed to discuss strategies and evidence needs that could accelerate vaccine introduction. The meeting, held in November 2024, was attended by Indonesian policymakers, researchers, health advocates and community representatives, alongside observers from immunization and TB programmes working at the global level, as well as donors. This report offers several key recommendations to ensure new TB vaccines for adults and adolescents are available, accessible and acceptable in Indonesia, as soon as possible after regulatory approval. The vaccine implementation strategy is expected to be through a stratified, geographical approach, initiating in provinces with the highest disease and socio-economic burden. As such, improved data on disease, infection prevalence and acceptability within different age cohorts and populations are needed to inform national and sub-national (e.g., province or district level) health and economic impact modelling. Early studies on knowledge, attitudes and practices of new TB vaccines for adults and adolescents will help to engage community leaders and advocates and ensure effective, culturally acceptable communication to improve acceptability. Of greatest urgency, a national strategic plan for new TB vaccine introduction, including a roadmap of critical activities, responsible entities and a stakeholder engagement plan are needed.
引用
- Alfaqeeh M, Ewart S, Tanoto R, et al. New adult and adolescent tuberculosis vaccines and Indonesia: policy planning and evidence, November 2024. Vaccine. 2025. PMID: 40695091. doi:10.1016/j.vaccine.2025.127490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。